IPP Bureau
Piramal Pharma Solutions commissions ADC manufacturing expansion in Scotland
By IPP Bureau - December 21, 2023
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
AGC invests US$ 348 million to expand its biopharmaceutical CDMO capability
By IPP Bureau - December 21, 2023
Development services for gene and cell therapies is planned to begin first in 2025
Norms for fixing prices of medicines
By IPP Bureau - December 20, 2023
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
NHA organizes a multi-stakeholder meet for ABDM microsites
By IPP Bureau - December 20, 2023
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
FDA grants priority review to Merck’s new biologics license application for V116
By IPP Bureau - December 20, 2023
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Clariant Healthcare debuts in CPhI India
By IPP Bureau - December 20, 2023
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
KBR and HJF bags contract to aid military neuroscience research
By IPP Bureau - December 20, 2023
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
Asahi Kasei opens new Bioprocess Technical Center in China
By IPP Bureau - December 20, 2023
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Venus Remedies' R3SET forays into wellness
By IPP Bureau - December 20, 2023
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
Briefs: Aurobindo Pharma and Granules Pharmaceuticals
By IPP Bureau - December 20, 2023
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
AstraZeneca Pharma India to launch Enhertu in January 2024
By IPP Bureau - December 20, 2023
Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
Vijaya Diagnostic to acquire P H Diagnostic for Rs. 134.65 Cr
By IPP Bureau - December 20, 2023
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
Biocon Academy conducts 8th Graduation Day
By IPP Bureau - December 19, 2023
Five batches across four programs of Biocon Academy participated in the graduation ceremony
CII recognized Cadila among Top 50 Innovative Companies in India
By IPP Bureau - December 19, 2023
Sanofi India appoints Himanshu Bakshi as GM - Consumer Healthcare Business
By IPP Bureau - December 19, 2023
His most recent stint was with Danone India as its Managing Director
